Page last updated: 2024-10-23

benzbromarone and Cardiovascular Diseases

benzbromarone has been researched along with Cardiovascular Diseases in 6 studies

Benzbromarone: Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
benzbromarone : 1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication.

Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Research Excerpts

ExcerptRelevanceReference
"Using the Korean National Health Insurance claims data (2002-17), we conducted a cohort study of 124 434 gout patients who initiated either allopurinol (n = 103 695) or benzbromarone (n = 20 739), matched on propensity score at a 5:1 ratio."8.02Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout. ( Kang, EH; Kim, SC; Park, EH; Shin, A; Song, JS, 2021)
"The object of this study was to evaluate the effect of uric acid lowering therapy in reducing the new development of comorbidities and the frequency of acute attacks in gout patients."7.80Prevention of comorbidity and acute attack of gout by uric acid lowering therapy. ( Joo, H; Joo, K; Jung, KH; Kwon, SR; Lim, MJ; Park, W, 2014)
"Using the Korean National Health Insurance claims data (2002-17), we conducted a cohort study of 124 434 gout patients who initiated either allopurinol (n = 103 695) or benzbromarone (n = 20 739), matched on propensity score at a 5:1 ratio."4.02Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout. ( Kang, EH; Kim, SC; Park, EH; Shin, A; Song, JS, 2021)
"The object of this study was to evaluate the effect of uric acid lowering therapy in reducing the new development of comorbidities and the frequency of acute attacks in gout patients."3.80Prevention of comorbidity and acute attack of gout by uric acid lowering therapy. ( Joo, H; Joo, K; Jung, KH; Kwon, SR; Lim, MJ; Park, W, 2014)
"Gout is a crystal deposition disease."2.44[Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia]. ( Fujimori, S, 2008)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Kang, EH1
Park, EH1
Shin, A1
Song, JS1
Kim, SC1
Sawada, S1
Kajiyama, K1
Shida, H1
Kimura, R1
Nakazato, Y1
Iguchi, T1
Oniyama, Y1
Ishiguro, C1
Uyama, Y1
Day, R1
Lee, H1
Graham, G1
Williams, K1
Joo, K1
Kwon, SR1
Lim, MJ1
Jung, KH1
Joo, H1
Park, W1
Hisatome, I1
Fujimori, S1

Reviews

2 reviews available for benzbromarone and Cardiovascular Diseases

ArticleYear
[Impact of serum uric acid level on the cardiovascular system as a risk factor].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2010, Volume: 136, Issue:6

    Topics: Adipokines; Benzbromarone; Cardiovascular Diseases; Hyperuricemia; Kidney; Organic Anion Transporter

2010
[Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].
    Nihon rinsho. Japanese journal of clinical medicine, 2008, Volume: 66, Issue:4

    Topics: Allopurinol; Benzbromarone; Cardiovascular Diseases; Gout; Gout Suppressants; Humans; Hyperuricemia;

2008

Other Studies

4 other studies available for benzbromarone and Cardiovascular Diseases

ArticleYear
Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout.
    European heart journal, 2021, 11-21, Volume: 42, Issue:44

    Topics: Allopurinol; Benzbromarone; Cardiovascular Diseases; Cohort Studies; Gout; Gout Suppressants; Heart

2021
Cardiovascular risk of urate-lowering drugs: A study using the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
    Clinical and translational science, 2023, Volume: 16, Issue:2

    Topics: Allopurinol; Benzbromarone; Cardiovascular Diseases; Febuxostat; Gout; Gout Suppressants; Heart Dise

2023
Benzbromarone: availability for general prescribing in New Zealand (a response to letters by Dr Lance Gravatt onbenzbromarone).
    The New Zealand medical journal, 2013, Sep-13, Volume: 126, Issue:1382

    Topics: Animals; Benzbromarone; Cardiovascular Diseases; Diabetes Mellitus; Female; Gout; Humans; Male; Uric

2013
Prevention of comorbidity and acute attack of gout by uric acid lowering therapy.
    Journal of Korean medical science, 2014, Volume: 29, Issue:5

    Topics: Adult; Allopurinol; Antimetabolites; Benzbromarone; Cardiovascular Diseases; Comorbidity; Diabetes M

2014